Navigation Links
Agios Pharmaceuticals' founders author Science review on cancer metabolism
Date:5/21/2009

in 1929, that cancer cells utilize sugar differently than normal cells, to a 2008 study published in the journal Nature showing that cancer cells 'switch on' the same highly active metabolizing enzymes as those found in fetal cells to promote rapid growth. This latter finding explains why cancer cells are able to divide and grow better than normal cells.

The vision of Agios is to lead the development and translation of cancer metabolism biology and decades of metabolic biochemistry into novel cancer therapeutics that will make a difference for patients. To date, Agios has put in place a world-class scientific team of more than 40 people, built a fully integrated cell metabolism platform within the largest research laboratory dedicated to cancer metabolism and created an emerging product development pipeline of novel Cancer Metabolism drugs.

"The Agios team, pipeline, platform and business strategy that we have built in a short time is exclusively focused on developing a deep biological understanding of the nexus of cancer and metabolism as the key driver behind where, when and how to cripple and kill a cancer cell," said Michael Su, Ph.D., Agios co-founder and Vice President, Drug Discovery. "This Science review, along with many other recent scientific advancements, continues to highlight the significance of the field and Agios' unique ability and position to lead the therapeutic exploration of cancer metabolism."


'/>"/>

Contact: Kathryn Morris
kathryn@kmorrispr.com
845-635-9828
Yates Public Relations
Source:Eurekalert

Page: 1 2

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
2. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 The Board of Governors of ... Hart LLP ’s Connie Akridge to serve as ... as President of the Foundation. Akridge served as President of ... a partner at Holland & Hart in Las Vegas, providing ... matters to insurance and healthcare clients for more than 25 ...
(Date:7/29/2014)... Many people complain about their dependence on eyeglasses. For ... put on glasses to see their clock or make their ... be dissatisfied with their vision even when using their glasses ... driving, especially at night due to glare. They can ... see the TV, sew or cross stitch, or read fine ...
(Date:7/29/2014)... Springs, LA (PRWEB) July 29, 2014 ... holiday across the United States usually celebrated throughout that ... recently though, those summer days now mark the start ... in crashes involving teen drivers. In 2012 nearly ... during the period from Memorial Day to Labor Day. ...
(Date:7/29/2014)... Avenidas is always looking for ... again, the non-profit agency is doing just that with the ... , This event gives seniors the opportunity to learn about ... will be a variety of fun activities, including a Tai ... and artists. In addition, there will be food tastings, courtesy ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Summer is here, and ... means enjoying a hike, swimming in a pool or laying out ... for fleas and ticks. The Puppy Store is here to help ... summer months. , It’s almost impossible to completely keep fleas and ... to minimize the chances of their pets coming into contact with ...
Breaking Medicine News(10 mins):Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:Avenidas Hosts Third Annual Successful Aging Celebration 2Health News:Protect Dogs From Fleas and Ticks During the Summer 2
... approach to the ... thoracolumbar spine, MARQUETTE, Mich., ... of the Cross-Fuse(TM) Lateral,Option System. The Cross-Fuse is Pioneer,s latest addition ... of the Los Angeles Orthopaedic Institute in,Sherman Oaks, California says, "The ...
... The Paul Bear Bryant,Awards committee of the American ... Coach Barry Switzer has been named the,2009 winner of ... the Lifetime Achievement Award at the Paul Bear,Bryant College ... Hyatt Regency Hotel in Houston. The award recognizes excellence ...
... from ground-breaking scientific trials of new interventional techniques ... - Transcatheter Cardiovascular Therapeutics the global annual ... will present a variety of new data that ... Featured trials will focus on the safety and ...
... Mach One,Corporation (Pink sheets: MNCN) ("Purchaser" or the ... letter of intent dated,September 26, 2008 related to a ... to acquire all of the outstanding common shares of,the ... completion of due,diligence by the Purchaser, the execution of ...
... Disabled Veterans, WASHINGTON, Sept. 29 The ... are supporting VA,s,newest rehabilitative event for injured veterans, ... fortunate to have such gracious sponsors to bring ... Dr. James B. Peake, Secretary of,Veterans Affairs. "For ...
... enrollment season,throughout corporate America is rapidly approaching, and ... decisions about their employee,benefit coverage for next year. ... emphasis on personal health behaviors as well as ... and programs, according to,benefit consultants at Watson Wyatt ...
Cached Medicine News:Health News:Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System 2Health News:Barry Switzer to Receive Paul 'Bear' Bryant Lifetime Achievement Award 2Health News:TCT update: press conference schedule announced for TCT 2Health News:TCT update: press conference schedule announced for TCT 3Health News:Mach One Corporation Enters Letter of Intent 2Health News:Mach One Corporation Enters Letter of Intent 3Health News:Watson Wyatt Identifies Trends for Benefits Open Enrollment Season 2Health News:Watson Wyatt Identifies Trends for Benefits Open Enrollment Season 3
(Date:7/29/2014)... Cynosure, Inc. (Nasdaq: ... aesthetic treatment systems for high-volume applications, today reported financial ... Second-quarter 2014 financial results incorporate the acquisition of Palomar ... Second-Quarter 2014 Financial Highlights ... million , Non-GAAP net income of $7.1 million, ...
(Date:7/29/2014)... TAIPEI , July 29, 2014 Apex Medical ... Therapy and Pressure Area Care sectors, announces that it is ... Munich in Germany that ... patent. Apex notes that it has initiated invalidity challenges against ... continuous efforts in counterattacking against trivial and junk patents. ...
(Date:7/29/2014)... 29, 2014  Novation, a VHA and UHC ... breakthrough interactive features that automate key health care ... Children,s Hospital Association.  The new ... umbrella – Value Analysis, Item Master and Formulary ... address the most critical challenges brought on by ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Apex Continues Fighting Against Patents to Free Up Competition 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5
... BUDAPEST, April 24 /CNW/ - The weight loss ... risk factors such as blood pressure, glycaemic,control and ... type,2 diabetes and hypertension, according to a study ... Budapest,Hungary.(1) , ,This analysis strengthens the wealth of ...
... WIRE)--Apr 25, 2007 - XenoPort, Inc.,(Nasdaq: XNPT) today ... of XP13512 for the treatment of symptoms of ... compared to placebo on both of the,co-primary endpoints ... results are very encouraging and represent a major,advance ...
Cached Medicine Technology:New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512,in Restless Legs Syndrome 2XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512,in Restless Legs Syndrome 3XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512,in Restless Legs Syndrome 4XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512,in Restless Legs Syndrome 5
... exceptional condensate of technology streamlined ... ensuring a rational and immediate ... professional market. PhotoLight is ideal ... studios who require greater practicality ...
... a CO2 laser system with CW intensities ... dealing with all therapeutic application in modern ... medium-to-high intensities in super-pulsed mode, designed for ... It is also capable of supplying soft ...
... offers HIPAA-secure web-based access to patient document ... week through the utilization of TrackDoc. ... to the original dictation at the same ... the document, and fax to referring physicians ...
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
Medicine Products: